Ved uge 48 havde 30, 4% patienter i Fuzeon + OB- gruppen en viral belastning < 400 kopier/ ml sammenlignet med 12% af patienterne i OB- gruppen.
The proportion of patients achieving viral load of < 400 copies/ ml at week 48 was 30.4% among patients on the Fuzeon+OB regimen compared to 12% among patients receiving OB regimen only.